ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election

October 22, 1999

National Breast Cancer Coalition Sets Goal To End Breast Cancer By Jan. 1, 2020

September 24, 2010

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996